I’m a Star Wars fan so I go into watching new Star Wars shows like the Obi-Wan Kenobi series already wanting to like them. It’s kind of akin to being a grant reviewer and being assigned a grant to review whose focus is already a passion of yours. However, after what I would call an […]
Obi-Wan Kenobi series review: lots to like but many plot holes Read More »
The last six months I’ve been spending even more time than usual writing NIH grants (and a few others). The last two weeks have been especially busy on this front as I am getting an R01 renewal out the door. My paper reading lately has been mostly related to the grant writing I’m doing. Still,
Weekly reads: NIH grants, side effect of darker hair, FDA warning, CRISPR Read More »
I grew up in the Seattle area so it wasn’t great to see stem cell clinics operating there recently, but better news was the WA State AG filing suit against a clinic there. The action included the clinic parent firm US Stemology along with its leader Dr. Tami Meraglia. The suit was filed only months ago
WA AG wins half million from Seattle stem cell clinic US Stemology Read More »
A new Nature paper argues that young CSF fights brain aging. Young CSF vs. young blood CSF is the cerebrospinal fluid that surrounds the brain, including those of young mice. The claim is that when young CSF is injected into the brain/CNS cavity of old mice, it makes the aged brains seem younger. And function
Nature paper claims young CSF fights brain aging in mice Read More »
The big news of the week was a $3.6 million settlement by a stem cell clinic, StemGenex, and one of its doctors in a class-action suit. I covered this StemGenex settlement and so did Michael Hiltzik of the LA Times and Paul Schloesser at Endpoints. I’d say this was good news for the stem cell field
Stem cell weekly reads: Jamie Thomson, Lamin B1, CRISPR Read More »
Before starting the umbilical cord cell supplier and marketing firm Liveyon, John Kosolcharoen was involved in some alleged health care fraud. The feds brought a case against him related to prescription drugs. Older case coming to a head As Liveyon was having its misadventures in the stem cell clinic sphere, the status of that past
Feds want $3M, prison for Liveyon founder in old fraud case Read More »
As long as I’ve been writing The Niche as a professor here at UC Davis School of Medicine, people have been asking me about stem cell therapy for COPD. There is a lot of misinformation out there in this space. Let’s clear things up as to where the biomedical science stands today in late 2023
Stem cell therapy for COPD: challenges & hope Read More »
The idea of stem cells outright curing diseases is exciting and has powerful appeal, but media need to be careful about using the word cure in headlines and articles as we saw this week related to a possible HIV Cure. HIV cure via stem cells and chemo? The big news of the week was that
Weekly reads: possible rare HIV cure, stem cell chicken, FDA commish Read More »
The last few years in the stem cell and regenerative medicine arena have been complicated in many ways. Variables like surging stem cell clinics and COVID have made predictions harder. Even so, trying to make predictions is useful and it’s fun to go over past year’s predictions. You can see my scorecard on my 2021
16 predictions for stem cells & regenerative medicine in 2022 Read More »
The world of stem cell research and regenerative medicine is unpredictable but it’s fun to be a part of it and try to do predictions. Each year in late December or early January I make prognostications for the coming year for stem cell research and regenerative medicine. I made 21 such predictions for the current
Grading my 21 stem cell & regenerative medicine predictions for 2021 Read More »